INVESTORS

enhancing shareholder value through exceptional business performance and practices, and through responsible and effective communication with its shareholders.

LATEST NEWS

SPHERIX ISSUES LETTER TO SHAREHOLDERS

New York, NY, June 28, 2017 /PRNewswire/ Spherix Incorporated (NASDAQ: SPEX) an intellectual property development company committed to the fostering of technology and monetization of intellectual property, today issued a letter to shareholders. Dear Spherix...

read more

SPHERIX INC. ANNOUNCES DEFINITIVE TERMS REACHED TO ACQUIRE CONTROLLING INTEREST IN HOTH THERAPEUTICS, A BIOPHARMACEUTICAL COMPANY DEVELOPING ITS BIOLEXA PLATFORM TO TREAT SKIN ILLNESS SUCH AS ECZEMA.

Hoth’s BioLexa platform uses its proprietary technology to treat eczema without the use of traditional topical steroids. New York, NY June 20, 2017 / PRNewswire/ Spherix Incorporated (NASDAQ: SPEX) announced today that the Company has negotiated definitive terms to...

read more